EK1136S

Human Serpin E1/PAI-1 Standard (人Serpin E1/纤溶酶原激活物抑制因子-1 (PAI-1) 标准品)

¥280.00

  • 分子靶点:SERPINE1, PAI1
  • 种属:人 (Human)
  • 试剂盒:EK1136
  • 保存:短期4℃保存,长期-20℃保存
  • 运输条件:4℃蓝冰运输

在售SKU:70-EK1136S


本产品只包含标准品试剂,如需购买试剂盒请点击下图

商品名

Human Serpin E1/PAI-1 Standard (人Serpin E1/纤溶酶原激活物抑制因子-1 (PAI-1) 标准品)

组分

人Serpin E1/PAI-1 标准品

板式

保存

短期4℃,长期-20℃保存

运输条件

4℃蓝冰运输

分子信息

概述人 SERPINE1, PAI1 靶点信息

SERPINE1 分子靶点信息概述

  • 分子名:SERPINE1, serpin family E member 1
  • 基因家族:Serpin peptidase inhibitors
  • 别名:PAI
  • 曾用名:PLANH1; PAI1
  • 全称:plasminogen activator inhibitor, type I; serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1

SERPINE1 分子靶点综述

Serpin E1,又名纤溶酶原激活物抑制因子-1 (PAI-1),是丝氨酸蛋白酶抑制剂超家族中的一员,主要由内皮(血管内皮衬里细胞)产生,但也由其他类型的组织如脂肪组织分泌产生。Serpin E1是尿激酶和组织型纤溶酶原激活剂(uPA和tPA)的主要抑制剂。PA-血纤维蛋白溶酶系统参与多种生理和病理过程如纤维蛋白溶解、纤维化、血管生成、伤口愈合、肿瘤细胞的侵袭和转移。例如,高水平的uPA和Serpin E1与乳腺癌患者的预后不良相关,研究证实uPA和Serpin E1的临床价值处于1级水平,是最可靠的生物标志物。除了乳腺癌,Serpin E1也参与许多其它疾病如代谢综合征、哮喘、重度抑郁症(MDD)以及衰老相关疾病。血浆中Serpin E1的缺失将导致异常出血,高水平的Serpin E1与遗传性易栓症相关。

人 Human SERPINE1 分子靶点信息

  • 分子名:SERPINE1, serpin family E member 1
  • 别称:
    • endothelial plasminogen activator inhibitor
    • PAI
    • PAI-1
    • PAI1
    • PLANH1
    • plasminogen activator inhibitor 1
    • serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
    • serpin E1
    • serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
  • 基因序列:NCBI_Gene: 5054
  • 蛋白序列:UniProtKB: P05121

人 Human SERPINE1靶点分子功能(预测)

Enables protease binding activity; serine-type endopeptidase inhibitor activity; and signaling receptor binding activity. Involved in several processes, including negative regulation of proteolysis; regulation of angiogenesis; and response to bacterium. Located in collagen-containing extracellular matrix and extracellular exosome. Implicated in several diseases, including artery disease (multiple); autoimmune disease (multiple); diabetic retinopathy (multiple); liver disease (multiple); and lung disease (multiple). Biomarker of several diseases, including artery disease (multiple); autoimmune disease (multiple); diabetic retinopathy (multiple); lung disease (multiple); and sleep apnea (multiple).

引用文献统计

ELISA标准品操作常见问题

查看更多ELISA标准品操作步骤技术文章

操作步骤

ELISA操作常见问题

查看更多ELISA操作相关问题

引用文献


  1. Knockdown of lncRNA NORAD inhibits the proliferation, inflammation and fibrosis of human mesangial cells under high‑glucose conditions by regulating the miR‑485/NRF1 axis 

  2. Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes 

  3. Helicobacter pylori-induced fibroblast-derived Serpin E1 promotes gastric cancer growth and peritoneal dissemination through p38 MAPK/VEGFA-mediated angiogenesis